Vivera Pharmaceuticals, Inc.

COVD-RT

DIAGNOSTIC KITS COMPRISED OF MEDICAL DIAGNOSTIC REAGENTS AND ASSAYS FOR TESTING OF BODILY FLUIDS FOR USE IN DISEASE DETECTION, namely, COVID-19; DIAGNOSTIC TESTING KITS COMPRISED OF MEDICAL DIAGNOSTIC REAGENTS AND ASSAYS THAT TEST FOR THE PRESENCE OF ANTIBODIES; DIAGNOSTIC REAGENTS FOR MEDICAL USE;

COVX-RT

DIAGNOSTIC KITS COMPRISED OF MEDICAL DIAGNOSTIC REAGENTS AND ASSAYS FOR TESTING OF BODILY FLUIDS FOR USE IN DISEASE DETECTION, namely, COVID-19; DIAGNOSTIC TESTING KITS COMPRISED OF MEDICAL DIAGNOSTIC REAGENTS AND ASSAYS THAT TEST FOR THE PRESENCE OF ANTIBODIES; DIAGNOSTIC REAGENTS FOR MEDICAL USE;

ENDO6

Camphor for medical purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Menthol for pharmaceutical purposes; Mentholated ointment for medical use; Pain relief medication; Pharmaceutical preparations for skin care; Pharmaceutical preparations for pain management; Pharmaceutical skin lotions; Multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; Preparation for the relief of pain; Topical gel for medical and therapeutic treatment of pain management;

ENDONESIC

Camphor for medical purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Menthol for pharmaceutical purposes; Mentholated ointment for medical use; Pain relief medication; Pharmaceutical preparations for skin care; Pharmaceutical preparations for pain management; Pharmaceutical skin lotions; Multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; Preparation for the relief of pain; Topical gel for medical and therapeutic treatment of pain management;

FOLINEX

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of prescription dosage capsules that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral capsules for the continuous release of a wide variety of therapeutic agents; all of the foregoing excluding pharmaceutical preparations and substances for the treatment of the central nervous system, sleep disorders, and neurological diseases or disorders;

SIL-K

Topical medicated patch for the treatment of scar tissue; topical medicated gel pad for treatment of scar tissue;

SILTREX

In the statement, line 5 after OF, DAMAGED SKIN AND is deleted, and OF SCAR is inserted. and in the statement, line 6 after FOR, SCAR TISSUE is inserted, and In the statement line 7 after DERMATOLOGY, NAMELY, SCAR TISSUE CARE AND MANAGEMENT is inserted, and In the statement line 7 after PRODUCTS, FOR USE IN SCAR TISSUE CARE AND MANAGEMENT is inserted, and In the statement line 9 after PREPARATIONS, FOR USE IN SCAR TISSUE CARE is inserted.;In the statement, line 1, (NEVADA CORPORATION) should be deleted, and (DELAWARE CORPORATION) should be inserted.;PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF [ DAMAGED SKIN AND ] * SCAR * TISSUE; PHARMACEUTICAL PREPARATIONS FOR * SCAR TISSUE * SKIN CARE; PHARMACEUTICAL PREPARATIONS FOR USE IN DERMATOLOGY *, namely, SCAR TISSUE CARE AND MANAGEMENT; * DERMATOLOGICAL PHARMACEUTICAL PRODUCTS * FOR USE IN SCAR TISSUE CARE AND MANAGEMENT; * DRUG DELIVERY AGENTS IN THE FORM OF GEL-MATRIX FILMS THAT FACILITATE THE DELIVERY OF PHARMACEUTICAL PREPARATIONS * FOR USE IN SCAR TISSUE CARE; * NONE OF THE AFORESAID * FOR USE IN THE TREATMENT OF WOUNDS OR * MARKETED TO PLASTIC OR COSMETIC SURGEONS PERFORMING IMPLANTS OR TISSUE EXPANSION OR DIRECTED FOR USE IN PLASTIC OR COSMETIC SURGERY RELATED TO IMPLANTS OR TISSUE EXPANDERS;

SOLUTECH

Topical medicated patch for the treatment of scar tissue; topical medicated gel pad for treatment of scar tissue;SOLUTION TECH;

SZOMAX

Cosmetics; cosmetic preparations for skin care; non-medicated skin care preparations; non-medicated anti-wrinkle and anti-aging skin care preparations; non-medicated anti-aging and anti-wrinkle creams, serums, moisturizers, lotions, toners, cleansers, creams, oils, gels for the skin; anti-aging creams, serums, moisturizers, lotions, toners, cleansers, creams, oils, gels; mon-medicated rejuvenating beauty creams, serums, moisturizers, lotions, toners, cleansers, creams, oils, gels; age spot reducing creams; non-medicated skin care preparations for skin renewal; wrinkle-minimizing cosmetic preparations for topical facial use; cosmetic pads; wipes, cloths or tissues impregnated with a skin cleanser;

SZOSIL

Topical medicated patch for the treatment of scar tissue; topical medicated gel sheets and pads for the treatment of scar tissue; medicated topical preparations, serums, gels and balms for the treatment of scar tissue;

THE FUTURE OF NON-ADDICTIVE PAIN MANAGEMENT

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of orodispersable tablets and/or sublingual tablets that facilitate the delivery of pharmaceutical preparations; Pain relief medication; Pharmaceutical preparations for the treatment and prevention of chronic pain; Pharmaceutical preparations for the treatment of the cardiovascular system, the circulatory system, the digestive system, the excretory system, the endocrine system, the integumentary system, the exocrine system, the lymphatic system, the immune system, the muscular system, the nervous system, the renal system, the urinary system, the reproductive system, and/or the skeletal system; Pharmaceutical preparations for non-addictive pain management; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Chemical preparations for pharmaceutical or medical purposes, namely, for non-addictive pain management; none of the foregoing items comprised of Cannabis sativa L with a delta-9 tetrahydrocannabinol (THC) content of more than 0.3 percent on a dry weight basis and none of which are comprised of cannabidiol (CBD);

TVIA

TOPICAL GEL FOR MEDICAL AND THERAPEUTIC TREATMENT OF PAIN AND INFLAMMATION; MEDICATED BODY PRODUCTS, NAMELY, GELS AND SALVES FOR SKIN, SKIN GELS, OINTMENTS AND CREAMS, ALL CONTAINING INGREDIENTS SOLELY DERIVED FROM INDUSTRIAL HEMP; TRANSDERMAL PATCHES FEATURING INGREDIENTS SOLELY DERIVED FROM INDUSTRIAL HEMP; ALL OF THE FOREGOING CONTAINING INGREDIENTS SOLELY DERIVED FROM HELP WITH A DELTA-9 TETRAHYROCANNABINOL (THC) CONCENTRATION OF NOT MORE THAN 0.3 PERCENT ON A DRY WEIGHT BASIS;

VISILAGE

Pharmaceutical agents for epidermis; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Dermatological pharmaceutical products; Drug delivery agents in the form of gel-matrix films that facilitate the delivery of pharmaceutical preparations;

XENIXAL

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of prescription dosage capsules that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents;

ZEINEX

Pharmaceutical agents for epidermis; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the treatment and prevention of dermatological disorders and skin conditions; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical skin lotions; Dermatological pharmaceutical products; Drug delivery agents in the form of creams and gels that facilitate the delivery of pharmaceutical preparations; Medical cleansers for skin and wounds; Medical preparations, namely, foot, hand and skin creams for diabetics; Medicated skin care preparations; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicated skin preparation for use in treating dermatological disorders and skin care; Medicinal creams for skin care; Nutritional supplements in lotion form sold as a component of nutritional skin care products;

ZYREXAL

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of prescription dosage capsules that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; all of the foregoing excluding pharmaceutical preparations and substances for the treatment of the central nervous system, sleep disorders, and neurological diseases or disorders;